Fatemeh Keramatnia

Title: Fatemeh Keramatnia: Innovator in Pharmaceutical Research

Introduction

Fatemeh Keramatnia is a prominent inventor based in Memphis, TN (US). She has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds that target specific proteins involved in various clinical conditions.

Latest Patents

Fatemeh holds 2 patents related to her innovative work. Her latest patents include substituted N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs as modulators of cereblon protein. These compounds are designed to modulate cereblon (CRBN) activity and can be utilized in treating disorders of uncontrolled cellular proliferation, such as cancer. The disclosed compounds can selectively modulate the degradation of GSPT1 protein, acting as GSPT1 degraders. This research is crucial for developing new therapeutic strategies for conditions associated with cereblon protein dysfunction.

Career Highlights

Fatemeh is currently affiliated with St. Jude Children's Research Hospital, where she continues her groundbreaking research. Her work has garnered attention for its potential impact on cancer treatment and other related disorders.

Collaborations

Fatemeh collaborates with esteemed colleagues, including Kevin McGowan and Jaeki Min, who contribute to her research endeavors and enhance the collaborative environment at St. Jude Children's Research Hospital.

Conclusion

Fatemeh Keramatnia is a dedicated inventor whose work in pharmaceutical research is paving the way for innovative treatments. Her contributions to the field are significant and hold promise for improving patient outcomes in various clinical conditions.